MitoKit-CII MitoPedia: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 13: Line 13:


*  [[SUIT-003_O2_ce_D060]] for living cells using [[MitoKit-CII/Succinate-nv]] and [[MitoKit-CII/Malonate-nv]].
*  [[SUIT-003_O2_ce_D060]] for living cells using [[MitoKit-CII/Succinate-nv]] and [[MitoKit-CII/Malonate-nv]].
*  [[SUIT-003 O2 ce D050]] for living cells using [[MitoKit-CII/Succinate-nv]].
*  [[SUIT-003_O2_ce_D050]] for living cells using [[MitoKit-CII/Succinate-nv]].


== Application in [[HRR]] ==
== Application in [[HRR]] ==

Revision as of 10:33, 2 July 2019


high-resolution terminology - matching measurements at high-resolution


MitoKit-CII MitoPedia

Description

Cell permeable prodrugs, composed of MitoKit-CII/Succinate-nv and MitoKit-CII/Malonate-nv, stimulates (Snv) or inhibits (Mnanv) mitochondrial respiration in CI-deficient human blood cells, fibroblasts and heart fibres, acting on Complex II of the electron transfer system.

Abbreviation: MitoKit-CII

Reference: MitoKit-CII, Ehinger 2016 Nat Commun


MitoPedia topics: Media for respirometry 


Specific SUIT protocols

Application in HRR

Preparation

Both compounds are dissolved in DMSO and stored in aliquots at -20 °C.
We recommend the following dilutions for reaching the desired concentration in the experiments:



SUITbrowser question: Permeable succinate/malonate

The cell permeable prodrugs Succinate-nv and Malonate-nv can help to answer questions related to the S-pathway in living cells. Use the SUITbrowser to find the best protocol to answer this and other research questions.
Cookies help us deliver our services. By using our services, you agree to our use of cookies.